• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚洛尔和普萘洛尔在高血压患者双盲交叉研究中的代谢效应

Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.

作者信息

Lithell H, Pollare T, Vessby B

机构信息

Department of Geriatrics, Uppsala University, Sweden.

出版信息

Blood Press. 1992 Aug;1(2):92-101. doi: 10.3109/08037059209077499.

DOI:10.3109/08037059209077499
PMID:1366265
Abstract

Metabolic effects of pindolol and propranolol were investigated in a randomised study of double-blind, double-dummy design in 39 Caucasians with newly detected hypertension. Each active treatment period was 6 months long. A euglycaemic hyperinsulinaemic clamp test was done to measure insulin sensitivity, and i.v. glucose tolerance was investigated with insulin determinations. Lipoprotein concentrations were quantified and lipoprotein lipase activities were determined in muscle and adipose tissue and in plasma after heparin injection. The blood pressure was significantly reduced by both regimes. The insulin sensitivity index was decreased by 34% during propranolol treatment and by 17% during pindolol treatment. The insulin concentrations in plasma were elevated at the end of the i.v. glucose tolerance test but were not high enough to compensate for the insulin resistance, so HbA1c and glucose concentrations were increased. A significant reduction of lipoprotein lipase activity in skeletal muscle during propranolol treatment probably explains the pronounced increase in serum triglyceride concentration during propranolol treatment despite lower free fatty acids and higher lipoprotein lipase activity in adipose tissue. These changes of lipoprotein lipase activity were not correlated to the changes in insulin sensitivity. In summary, the metabolic effects were significantly less pronounced with pindolol than with propranolol, which probably can be ascribed to the agonistic effect of pindolol on beta 2 adrenoceptors.

摘要

在一项针对39名新诊断为高血压的高加索人的随机双盲双模拟设计研究中,对吲哚洛尔和普萘洛尔的代谢效应进行了调查。每个积极治疗期为6个月。进行了正常血糖高胰岛素钳夹试验以测量胰岛素敏感性,并通过胰岛素测定研究静脉内葡萄糖耐量。对脂蛋白浓度进行了定量,并在肝素注射后测定了肌肉、脂肪组织和血浆中的脂蛋白脂肪酶活性。两种治疗方案均使血压显著降低。在普萘洛尔治疗期间,胰岛素敏感性指数降低了34%,在吲哚洛尔治疗期间降低了17%。静脉内葡萄糖耐量试验结束时,血浆胰岛素浓度升高,但不足以补偿胰岛素抵抗,因此糖化血红蛋白和血糖浓度升高。普萘洛尔治疗期间骨骼肌中脂蛋白脂肪酶活性显著降低,这可能解释了尽管脂肪组织中游离脂肪酸含量较低且脂蛋白脂肪酶活性较高,但普萘洛尔治疗期间血清甘油三酯浓度仍显著升高的原因。脂蛋白脂肪酶活性的这些变化与胰岛素敏感性的变化无关。总之,吲哚洛尔的代谢效应明显不如普萘洛尔显著,这可能归因于吲哚洛尔对β2肾上腺素能受体的激动作用。

相似文献

1
Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.吲哚洛尔和普萘洛尔在高血压患者双盲交叉研究中的代谢效应
Blood Press. 1992 Aug;1(2):92-101. doi: 10.3109/08037059209077499.
2
Comparison of the effect of pindolol vs propranolol on the lipid profile in patients treated for hypertension.吲哚洛尔与普萘洛尔对高血压治疗患者血脂谱影响的比较。
Br J Clin Pharmacol. 1987;24 Suppl 1(Suppl 1):63S-64S. doi: 10.1111/j.1365-2125.1987.tb03273.x.
3
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.短期β-肾上腺素能受体阻滞剂对高血压或冠状动脉疾病患者血脂和脂蛋白的影响。
Br Heart J. 1984 Jun;51(6):589-94. doi: 10.1136/hrt.51.6.589.
4
Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment.在长期抗高血压治疗期间,伊拉地平单药治疗或与吲哚洛尔联合使用的代谢效应。
J Intern Med. 1994 Jul;236(1):37-42. doi: 10.1111/j.1365-2796.1994.tb01117.x.
5
Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.阿替洛尔和美托洛尔治疗期间对胰岛素的敏感性:高血压患者碳水化合物和脂蛋白代谢影响的随机双盲研究。
BMJ. 1989 Apr 29;298(6681):1152-7. doi: 10.1136/bmj.298.6681.1152.
6
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.阿替洛尔、美托洛尔、吲哚洛尔和缓释普萘洛尔每日一次随机双盲给药期间的动态血压
Br Med J (Clin Res Ed). 1982 Nov 13;285(6352):1387-92. doi: 10.1136/bmj.285.6352.1387.
7
Comparative beta-adrenoreceptor-blocking effects and pharmacokinetics or propranolol and pindolol in hypertensive Africans.高血压非洲人群中普萘洛尔与吲哚洛尔的β-肾上腺素受体阻断作用及药代动力学比较
Clin Sci (Lond). 1979 Dec;57 Suppl 5:393s-396s. doi: 10.1042/cs057393s.
8
Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
J Cardiovasc Pharmacol. 1990 Jun;15(6):911-7. doi: 10.1097/00005344-199006000-00008.
9
Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions.β-肾上腺素能受体阻滞与血浆脂蛋白。普萘洛尔和吲哚洛尔对包括高密度脂蛋白亚组分在内的血浆脂蛋白影响的比较。
Clin Sci (Lond). 1987 May;72(5):549-56. doi: 10.1042/cs0720549.
10
Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.α-和β-肾上腺素能拮抗剂对轻度高血压患者血浆载脂蛋白及前臂血流量的影响。
Am J Med. 1989 Jan 23;86(1B):8-13. doi: 10.1016/0002-9343(89)90121-6.

引用本文的文献

1
β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress.β受体阻滞剂与代谢调节:揭示与葡萄糖代谢、炎症和氧化应激的复杂相互作用
Front Pharmacol. 2024 Dec 20;15:1489657. doi: 10.3389/fphar.2024.1489657. eCollection 2024.
2
Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies.药物性高血糖与糖尿病:当前文献综述及实际管理策略
Diabetes Ther. 2024 Sep;15(9):2001-2025. doi: 10.1007/s13300-024-01628-0. Epub 2024 Jul 31.
3
Cardiovascular disease and risk of incident diabetes mellitus: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
心血管疾病与新发糖尿病风险:来自西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)的结果。
J Diabetes. 2021 Dec;13(12):1043-1053. doi: 10.1111/1753-0407.13224. Epub 2021 Oct 11.
4
Metabolic effects of carvedilol through β-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts.卡维地洛通过β-arrestin 蛋白的代谢作用:链脲佐菌素诱导糖尿病大鼠模型和 C2C12 成肌细胞中的研究。
Br J Pharmacol. 2020 Dec;177(24):5580-5594. doi: 10.1111/bph.15269. Epub 2020 Nov 15.
5
Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.β肾上腺素受体阻滞剂引起的外周血管收缩:一项系统评价和网状Meta分析。
Br J Clin Pharmacol. 2016 Aug;82(2):549-60. doi: 10.1111/bcp.12980. Epub 2016 May 31.
6
Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.药物性雷诺现象:超越β-肾上腺素能受体阻滞剂
Br J Clin Pharmacol. 2016 Jul;82(1):6-16. doi: 10.1111/bcp.12912. Epub 2016 Apr 7.
7
Antihypertensive drugs and glucose metabolism.抗高血压药物与葡萄糖代谢。
World J Cardiol. 2014 Jul 26;6(7):517-30. doi: 10.4330/wjc.v6.i7.517.
8
Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.在治疗高血压的同时保护心脏代谢综合征中脆弱的胰岛。
J Am Soc Hypertens. 2008 Jul-Aug;2(4):239-66. doi: 10.1016/j.jash.2007.12.002. Epub 2008 Jun 2.
9
Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.伊伐布雷定对永久性窦性心动过速心脏移植受者移植心脏功能及运动能力的影响。
Clin Res Cardiol. 2008 Nov;97(11):811-9. doi: 10.1007/s00392-008-0690-5. Epub 2008 Jul 21.
10
Carvedilol in hypertension treatment.卡维地洛在高血压治疗中的应用
Vasc Health Risk Manag. 2008;4(1):23-30. doi: 10.2147/vhrm.2008.04.01.23.